A Flawed Trial Design Cost $30 Billion — Could AI Have Prevented It?

Using the Opdivo vs. Keytruda PD1 rivalry as an example, commentators argue that a poorly designed clinical trial can cost around $30 billion, and translational AI could help avoid such costly mistakes in drug development.

2026-09-25 ~ 2026-09-25 · 2 related posts

• A $30B trial-design blunder: the case for translational AI in pharma — hardimanjames · 2026-09-25
• A single bad trial design may have cost ~$30B — where translational AI could help — hardimanjames · 2026-09-25